Abstract
Background: Urinary tract infection is a widespread microbial disease and 2nd most disease in women due to the anatomy of women type 2 diabetes is a high risk of infection of the urinary tract. Objective: To identify the agent that causes urinary tract infections in diabetic patients, select the best antibiotic, and assess the types of diabetes that are connected with urinary tract infections. Materials and Methods: From May to August 2018, a hospital-based cross- sectional study was carried out. According to the established methodology, urine samples were obtained for culture and identification. All isolates underwent an antimicrobial susceptibility test (AST) using the Kirby-Bauer disk diffusion method. The Statistical Package for the Social Science (SPSS) version 20 was used to import the data from Epi-data version 3.2.1. Results: The study's findings indicated that E. coli is the most prevalent bacterium, with a prevalence of approximately (30.2%). It is followed by K. pneumoniae (26.3%), and then by Staphylococcus aureus and Saprophiticus in percentage (15%). Gentamicin has a high rate of antibiotic sensitivity (approximately 36%), while Ceftazidime has a high rate of antibiotic resistance (about 35%). Around (52%) of people are resistant to Ceftriaxone and Cloxacillin. Conclusions: There was a high rate of UTI in diabetes patients. Female diabetics were more likely to experience UTIs than male diabetics.E. coli and K. pneumoniae species making up the majority of isolates. The isolated pathogens were highly susceptible to Gentamicin, Cloxacillin, and Ceftriaxone. These findings demonstrate the importance of glycemic management in diabetics for reducing UTIs, regardless of age or sex. By treating UTIs with the appropriate antimicrobial medications and monitoring the antimicrobial susceptibility patterns of isolated microorganisms, antibiotic-resistant urinary organisms can be managed.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
